Health Care, Law & Legal, Lifestyle, News Now!, Science, Technology

Flow neuroscience CEO calls out FDA regulations that it plays waiting game with clinically proven depression treatments: Locked out of US when millions of Americans suffer from depression

LONDON, UK — A growing number of neuromodulation headsets are flooding the U.S. market, often sold under wellness labels with vague claims like “improved mood” or “mental focus.” Yet, many lack clinical validation. Meanwhile, transcranial direct current stimulation (tDCS) devices, which have passed